Phase 1 Clinical Trials Program

Karmanos’ Phase 1 Clinical Trials Multidisciplinary Team conducts clinical research studies with new, investigational cancer drugs.

Phase 1 trials are the first stage of clinical trials in the careful process of developing new cancer treatments. A typical Phase 1 clinical trial evaluates how a new drug should be given, either orally or injected into the blood, how often, and what dosage is safe. A Phase I trial is often the first time a drug has been given to human, or the first time a new drug has been given to a human in combination with another standard cancer treatment.

Evaluation and Diagnosis

Each patient receives personal attention from the Phase 1 Team. All patients considered for a Phase 1 clinical trial must go through an initial screening consultation to determine if they are eligible for a research study and if a clinical trial is their best treatment option.

Patient safety and care are our top priorities. Phase 1 Team physicians, nurse practitioners and physician assistants monitor patients carefully for any changes in their condition and will maintain close contact with referring physicians. Patients may opt-out of a clinical trial at any time.

Innovative, Individualized Care

Here’s what patients can expect from our Phase 1 Clinical Trials Multidisciplinary Team:

  • A passionate, caring, expert team, giving the best chance of success.
  • A collaborative approach that considers all available treatment options.
  • A carefully constructed treatment plan designed to achieve the best possible outcome.
  • Respectful, compassionate care that is responsive to the emotional needs and lifestyle of a patient.
  • Proactive, timely communication with patients, caregivers and the referring physician.

Appointment Information

Request an Appointment Online Request an Appointment By Phone

The Latest From Karmanos Cancer Institute

News

Karmanos’ Community Outreach and Engagement Office Honored as Hometown Health Hero by the Michigan Public Health Week Partnership

The Barbara Ann Karmanos Cancer Institute’s Office of Community Outreach and Engagement (COE) has been named a 2025 Hometown Health Hero by the Mi...

Read More

Karmanos Recommended Nationwide by Optum for Transplants

The Barbara Ann Karmanos Cancer Institute has been named one of 168 medical centers in the country to which Optum recommends its payers refer thei...

Read More

The HPV Link: Understanding How It Can Lead to Head and Neck Cancer

Human papillomavirus (HPV) is common and widespread virus, and about 85% of people will get an HPV infection in their lives. According to the Cent...

Read More
News

WDET | Doctor Says HPV Vaccine and Routine Screenings Aid Against Cervical Cancer

Listen Now

WWJ | World Cancer Day

Listen Now

WWJ | Ribbon Cutting Held for New Karmanos Cancer Center in Dearborn That Strives to Improve Access to Treatment, Clinical Trials

Listen Now